Literature DB >> 20443985

Quality of life, caregiver burden and insurance in patients with Parkinson's disease in Germany.

T Müller1, D Woitalla.   

Abstract

BACKGROUND: German health politicians claim that maintenance and thus quality of life (QoL) of patients with chronic disease do not differ between the various healthcare insurance systems in Germany. Patient organizations i.e. the Deutsche Parkinson Vereinigung for patients with Parkinson's disease (PD), physicians, patients themselves and their carers controversially discuss this opinion making by politicians.
METHODS: We performed a survey to analyse the relations between QoL, insurance, disability and caregiver burden in 2603 patients with PD and their carers.
RESULTS: Insurance with private reimbursement provides a significant better self-reported patient disability and QoL according to the various employed rating instruments in patients with PD. Government employees with PD, who have additional private insurance, demand for significant shorter intervals of care giving by their carers. In general, caregiver burden did not significantly differ between patients with PD of the different healthcare insurance systems.
CONCLUSION: At least in Germany, obligatory medical insurance with associated state regulation of health care is inferior to private reimbursement insurance in various domains of QoL.
© 2010 The Author(s). Journal compilation © 2010 EFNS.

Entities:  

Mesh:

Year:  2010        PMID: 20443985     DOI: 10.1111/j.1468-1331.2010.03033.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

Review 1.  Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Authors:  Matthias Löhle; Carl-Johan Ramberg; Heinz Reichmann; Anthony H V Schapira
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

2.  Benefit on motor and non-motor behavior in a specialized unit for Parkinson's disease.

Authors:  Thomas Müller; Gabi Öhm; Kathrin Eilert; Katharina Möhr; Stephanie Rotter; Thomas Haas; Matthias Küchler; Sven Lütge; Marion Marg; Hartmut Rothe
Journal:  J Neural Transm (Vienna)       Date:  2017-02-28       Impact factor: 3.575

3.  Tolcapone addition improves Parkinson's disease associated nonmotor symptoms.

Authors:  Thomas Müller
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

4.  Lack of information and access to advanced treatment for Parkinson's disease patients.

Authors:  J Lökk
Journal:  J Multidiscip Healthc       Date:  2011-12-13

5.  Costs of Parkinson's disease in a privately insured population.

Authors:  Scott J Johnson; Anna Kaltenboeck; Melissa Diener; Howard G Birnbaum; Elizabeth Grubb; Jane Castelli-Haley; Andrew D Siderowf
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

6.  Factors associated with quality of life among chronic kidney disease patients in Nepal: a cross-sectional study.

Authors:  Shambhu Kumar Saxena Mahato; Tawatchai Apidechkul; Pamornsri Sriwongpan; Rajani Hada; Guna Nidhi Sharma; Shravan Kumar Nayak; Ram Kumar Mahato
Journal:  Health Qual Life Outcomes       Date:  2020-06-29       Impact factor: 3.186

7.  Relationship between internet use intensity and quality of life in chronic patients during the COVID-19 pandemic: The role of physical exercise and health insurance.

Authors:  Yangyang Wang; Jian Xu; Tian Xie
Journal:  Front Public Health       Date:  2022-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.